Age and aging in blood disorders: multiple myeloma

Haematologica. 2014 Jul;99(7):1133-7. doi: 10.3324/haematol.2014.110296.

Authors

Sonja Zweegman¹, Antonio Palumbo², Sara Bringhen², Pieter Sonneveld³

Affiliations

¹ Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.
² Department of Hematology, University of Torino, Italy.
³ Department of Hematology, Erasmus Medical Center, Rotterdam, the Netherlands p.sonneveld@erasmusmc.nl.

No abstract available

Publication types

Editorial

MeSH terms

Age Factors
Aged
Aged, 80 and over
Aging*
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Humans
Immunologic Factors / therapeutic use
Multiple Myeloma / drug therapy*
Proteasome Inhibitors / therapeutic use
Standard of Care
Treatment Outcome

Substances

Immunologic Factors
Proteasome Inhibitors